These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 443080

  • 1. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Short-term effect of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol.
    Mosekilde L, Hansen HH, Christensen MS, Lund B, Sørensen OH, Melsen F, Norman AW.
    Acta Med Scand; 1979; 205(5):405-9. PubMed ID: 443080
    [Abstract] [Full Text] [Related]

  • 2. Effect of phenytoin on bone and vitamin D metabolism.
    Bell RD, Pak CY, Zerwekh J, Barilla DE, Vasko M.
    Ann Neurol; 1979 Apr; 5(4):374-8. PubMed ID: 220903
    [Abstract] [Full Text] [Related]

  • 3. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration.
    Hahn TJ, Halstead LR.
    Calcif Tissue Int; 1979 Mar 13; 27(1):13-8. PubMed ID: 223750
    [Abstract] [Full Text] [Related]

  • 4. The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
    Mosekilde L, Christensen MS, Lund B, Sorensen OH, Melsen F.
    Acta Endocrinol (Copenh); 1977 Mar 13; 84(3):559-65. PubMed ID: 576530
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical variables related to calcium metabolism in epileptics.
    Dymling JF, Lidgren L, Wallöe A.
    Acta Med Scand; 1979 Mar 13; 205(5):401-4. PubMed ID: 443079
    [Abstract] [Full Text] [Related]

  • 8. Calcium and folic acid absorption in patients taking anticonvulsant drugs.
    Shafer RB, Nuttall FQ.
    J Clin Endocrinol Metab; 1975 Dec 13; 41(06):1125-9. PubMed ID: 173736
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of long-term vitamin D2 treatment on bone morphometry and biochemical values in anticonvulsant osteomalacia.
    Mosekilde L, Melsen F, Christensen MS, Lund B, Sorenson OH.
    Acta Med Scand; 1977 Dec 13; 201(4):303-7. PubMed ID: 300547
    [Abstract] [Full Text] [Related]

  • 11. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB, Phillips ME, de Wardener HE, Bordier J, Marie P, Arnaud CD, Norman AW.
    J Urol Nephrol (Paris); 1974 Dec 13; 80(12):984-5. PubMed ID: 4617780
    [No Abstract] [Full Text] [Related]

  • 12. Action of 1,25-dihydroxycholecalciferol in normal and uraemic man.
    Coburn JW, Brickman AS, Massry SG, Singer FR, Norman AW.
    Proc Eur Dial Transplant Assoc; 1973 Dec 13; 10(0):210-6. PubMed ID: 4802387
    [No Abstract] [Full Text] [Related]

  • 13. Effects of 1,25-dihydroxycholecalciferol on calcium absorption, muscle weakness, and bone disease in chronic renal failure.
    Henderson RG, Russell RG, Ledingham JG, Smith R, Oliver DO, Walton RJ, Small DG, Preston C, Warner GT.
    Lancet; 1974 Mar 09; 1(7854):379-84. PubMed ID: 4131033
    [No Abstract] [Full Text] [Related]

  • 14. Reduced 2,25-dihydroxyvitamin D and 24,25-dihydroxyvitamin D in epileptic patients receiving chronic combined anticonvulsant therapy.
    Christensen CK, Lund B, Lund BJ, Sørensen OH, Nielsen HE, Mosekilde L.
    Metab Bone Dis Relat Res; 1981 Mar 09; 3(1):17-22. PubMed ID: 6973685
    [Abstract] [Full Text] [Related]

  • 15. Physiological and pharmacological aspects of 24,25-dihydroxycholecalciferol in man.
    Russell RG, Kanis JA, Smith R, Adams ND, Bartlett M, Cundy T, Cochran M, Heynen G, Warner GT.
    Adv Exp Med Biol; 1978 Mar 09; 103():487-503. PubMed ID: 362853
    [Abstract] [Full Text] [Related]

  • 16. Unique effects of 24,25-dihydroxyvitamin D3 in uremic patients.
    Llach F, Brickman AS, Coburn JW.
    Contrib Nephrol; 1980 Mar 09; 18():212-7. PubMed ID: 7353377
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
    Davies M, Mawer EB, Adams PH.
    J Clin Endocrinol Metab; 1977 Aug 09; 45(2):199-208. PubMed ID: 195972
    [Abstract] [Full Text] [Related]

  • 18. [Effect of 1,25-dihydroxycholecalciferol in renal osteopathy].
    Reutter FW, Sieber R, Olah AJ, Dambacher MA.
    Schweiz Med Wochenschr; 1979 Dec 08; 109(47):1880-3. PubMed ID: 531567
    [Abstract] [Full Text] [Related]

  • 19. Treatment of renal osteodystrophy with 1,25-dihydroxycholecalciferol.
    Velentzas C, Oreopoulos DG, Pierratos A, Meema HE, Rabinovich S, Meindok H, Husdan H, Murray TM, Ogilvie R, Katirtzoglou A.
    Can Med Assoc J; 1981 Mar 01; 124(5):577-83. PubMed ID: 6894103
    [Abstract] [Full Text] [Related]

  • 20. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE, Clemens TL, Fraher LJ, Gleed J, O'Riordan JL.
    Lancet; 1980 Sep 20; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.